299 related articles for article (PubMed ID: 34875227)
1. Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity.
Schnell A; Huang L; Singer M; Singaraju A; Barilla RM; Regan BML; Bollhagen A; Thakore PI; Dionne D; Delorey TM; Pawlak M; Meyer Zu Horste G; Rozenblatt-Rosen O; Irizarry RA; Regev A; Kuchroo VK
Cell; 2021 Dec; 184(26):6281-6298.e23. PubMed ID: 34875227
[TBL] [Abstract][Full Text] [Related]
2. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
3. CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis.
Hou L; Yuki K
Front Immunol; 2022; 13():819224. PubMed ID: 35178050
[TBL] [Abstract][Full Text] [Related]
4. Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β.
Komuczki J; Tuzlak S; Friebel E; Hartwig T; Spath S; Rosenstiel P; Waisman A; Opitz L; Oukka M; Schreiner B; Pelczar P; Becher B
Immunity; 2019 May; 50(5):1289-1304.e6. PubMed ID: 31079916
[TBL] [Abstract][Full Text] [Related]
5. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
O'Connor RA; Cambrook H; Huettner K; Anderton SM
Eur J Immunol; 2013 Nov; 43(11):2818-23. PubMed ID: 23878019
[TBL] [Abstract][Full Text] [Related]
6. CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.
Kara EE; McKenzie DR; Bastow CR; Gregor CE; Fenix KA; Ogunniyi AD; Paton JC; Mack M; Pombal DR; Seillet C; Dubois B; Liston A; MacDonald KPA; Belz GT; Smyth MJ; Hill GR; Comerford I; McColl SR
Nat Commun; 2015 Oct; 6():8644. PubMed ID: 26511769
[TBL] [Abstract][Full Text] [Related]
7. IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production.
Yoshimura S; Thome R; Konno S; Mari ER; Rasouli J; Hwang D; Boehm A; Li Y; Zhang GX; Ciric B; Rostami A
J Immunol; 2020 Feb; 204(3):531-539. PubMed ID: 31852750
[TBL] [Abstract][Full Text] [Related]
8. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
9. Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis.
Lee PW; Yang Y; Racke MK; Lovett-Racke AE
Brain Behav Immun; 2015 May; 46():44-9. PubMed ID: 25499467
[TBL] [Abstract][Full Text] [Related]
10. Tbet or Continued RORγt Expression Is Not Required for Th17-Associated Immunopathology.
Brucklacher-Waldert V; Ferreira C; Innocentin S; Kamdar S; Withers DR; Kullberg MC; Veldhoen M
J Immunol; 2016 Jun; 196(12):4893-904. PubMed ID: 27183623
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic function of bystander-activated memory-like CD4
Lee HG; Lee JU; Kim DH; Lim S; Kang I; Choi JM
Nat Commun; 2019 Feb; 10(1):709. PubMed ID: 30755603
[TBL] [Abstract][Full Text] [Related]
12. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation.
Kumar P; Monin L; Castillo P; Elsegeiny W; Horne W; Eddens T; Vikram A; Good M; Schoenborn AA; Bibby K; Montelaro RC; Metzger DW; Gulati AS; Kolls JK
Immunity; 2016 Mar; 44(3):659-671. PubMed ID: 26982366
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.
Lee YK; Menezes JS; Umesaki Y; Mazmanian SK
Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4615-22. PubMed ID: 20660719
[TBL] [Abstract][Full Text] [Related]
15. The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
Brüstle A; Brenner D; Knobbe CB; Lang PA; Virtanen C; Hershenfield BM; Reardon C; Lacher SM; Ruland J; Ohashi PS; Mak TW
J Clin Invest; 2012 Dec; 122(12):4698-709. PubMed ID: 23114599
[TBL] [Abstract][Full Text] [Related]
16. Diverting T helper cell trafficking through increased plasticity attenuates autoimmune encephalomyelitis.
Califano D; Sweeney KJ; Le H; VanValkenburgh J; Yager E; O'Connor W; Kennedy JS; Jones DM; Avram D
J Clin Invest; 2014 Jan; 124(1):174-87. PubMed ID: 24316973
[TBL] [Abstract][Full Text] [Related]
17. Interferon-β Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease.
Agasing A; Quinn JL; Kumar G; Axtell RC
Cells; 2021 Aug; 10(8):. PubMed ID: 34440908
[TBL] [Abstract][Full Text] [Related]
18. Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation.
Morrison PJ; Bending D; Fouser LA; Wright JF; Stockinger B; Cooke A; Kullberg MC
Mucosal Immunol; 2013 Nov; 6(6):1143-56. PubMed ID: 23462910
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
[TBL] [Abstract][Full Text] [Related]
20. Steady-state memory-phenotype conventional CD4
Cho MJ; Lee HG; Yoon JW; Kim GR; Koo JH; Taneja R; Edelson BT; Lee YJ; Choi JM
Exp Mol Med; 2023 May; 55(5):1033-1045. PubMed ID: 37121980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
